What Changed
Price Move History
- Daily moves over 5%
- 11 26 sessions, October 6, 2025 to October 13, 2026
- Largest daily move
- +65.6% close of May 26, 2026
- 1-year change
- +10% closing prices, October 6, 2025 to October 13, 2026
Company Description
Translational Development Acquisition Units (NASDAQ: TDACU) is classified in the shell companies industry within the Financial Services sector.
TDACU has gained 10.0% over the past year. The last closing price was $11.48.
For FY2025, Translational Development Acquisition Units reported net income of $6.4M.
This page collects what Stock Titan holds for TDACU, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
Translational Development Acquisition Units (TDACU) closed at $11.48 on October 13, 2026. Over the past 12 months, the price has gained 10.0%.
TDACU Metrics & Rankings
Price returns through October 13, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Translational Development Acquisition Units has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, IPO, offering. View all TDACU news →
SEC Filings
Translational Development Acquisition Units has filed 10 recent SEC filings, including 5 Form 8-K, 2 Form SCHEDULE 13G, 2 Form SCHEDULE 13G/A, 1 Form 10-Q. The most recent filing was submitted on August 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TDACU SEC filings →
Financial Highlights
operating income reached -$945K, and net income was $6.4M. The company generated -$608K in operating cash flow. The current ratio was 0.07, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Translational Development Acquisition Units (TDACU) currently stands at 3 shares, down 50.0% from the previous reporting period. Since November 2025, short interest has increased by 200.0%.
Days to Cover History
Days to cover for Translational Development Acquisition Units (TDACU) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 3.0 days.
TDACU Company Profile & Sector Positioning
Translational Development Acquisition Units (TDACU) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.
Investors comparing TDACU often look at related companies in the same sector, including Bold Eagle Acquisition Corp. Units (BEAGU), Aldel Financial II Inc. Units (ALDFU), Cayson Acquisition Corp Unit (CAPNU), Charlton Aria Acquisition Corporation Units (CHARU), and Future Vision II Acquisition Corporation Units (FVNNU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TDACU's relative position within its industry.